Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chase Chemical Company was a prominent manufacturer of soft gelatin capsules (softgels) for the pharmaceutical and nutritional industries. Based in Newark, New Jersey, the company specialized in the encapsulation of over-the-counter (OTC) medications, vitamins, and supplements. It was a significant competitor in the softgel market before being acquired by RP Scherer Corporation in 1988. Through subsequent mergers and acquisitions, its legacy operations became part of Cardinal Health and eventually Catalent. The company was known for its high-quality manufacturing standards and its role in the growth of the softgel dosage form in the mid-20th century.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chase Chemical Co.